Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2005-10-11
2005-10-11
Pak, Michael (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120, C435S091200, C536S024310
Reexamination Certificate
active
06953668
ABSTRACT:
This invention provides for an isolated mammalian nucleic acid molecule encoding a mammalian prostate-specific membrane antigen. This invention provides for nucleic acid probes which specifically hybridize with the nucleic acid molecule encoding said antigen. This invention provides for a method of detecting hematogenous micrometastic tumor cells of a subject performing the polymerase chain reaction (PCR) on samples of the subject using primers of said antigen. This invention provides for methods to identify ligands which bind to said antigen. This invention provides for the prevention and/or treatment of prostate tumor growth.
REFERENCES:
patent: 4554101 (1985-11-01), Hopp
patent: 4939240 (1990-07-01), Chu et al.
patent: 5162504 (1992-11-01), Horoszewicz
patent: 5538866 (1996-07-01), Israeli et al.
patent: 5672592 (1997-09-01), Jackson et al.
patent: 5773292 (1998-06-01), Bander
patent: 5795877 (1998-08-01), Jackson
patent: 5804602 (1998-09-01), Slusher et al.
patent: 5863536 (1999-01-01), Jackson et al.
patent: 5880112 (1999-03-01), Jackson et al.
patent: 5902817 (1999-05-01), Jackson et al.
patent: 5935818 (1999-08-01), Israeli et al.
patent: 5939258 (1999-08-01), Croce et al.
patent: 5962521 (1999-10-01), Jackson et al.
patent: 5968915 (1999-10-01), Jackson et al.
patent: 5981209 (1999-11-01), Slusher et al.
patent: 6011021 (2000-01-01), Slusher et al.
patent: 6017903 (2000-01-01), Slusher et al.
patent: 6025344 (2000-02-01), Jackson et al.
patent: 6025345 (2000-02-01), Jackson et al.
patent: 6046180 (2000-04-01), Jackson et al.
patent: 6054444 (2000-04-01), Jackson et al.
patent: 6103463 (2000-08-01), Chetverin et al.
patent: 6107090 (2000-08-01), Bander
patent: 6121252 (2000-09-01), Jackson et al.
patent: 6136311 (2000-10-01), Bander
patent: 6150508 (2000-11-01), Murphy et al.
patent: 6271245 (2001-08-01), Jackson et al.
patent: 6288046 (2001-09-01), Jackson et al.
patent: 6348464 (2002-02-01), Jackson et al.
patent: 6372726 (2002-04-01), Slusher et al.
patent: 6384022 (2002-05-01), Jackson et al.
patent: 6395718 (2002-05-01), Slusher et al.
patent: 6413948 (2002-07-01), Slusher et al.
patent: 6452044 (2002-09-01), Jackson et al.
patent: 6458775 (2002-10-01), Jackson et al.
patent: 6479471 (2002-11-01), Jackson et al.
patent: 6569432 (2003-05-01), Israeli et al.
patent: 6586623 (2003-07-01), Tsukamoto et al.
patent: 6649163 (2003-11-01), Bander
patent: 2001/0044459 (2001-11-01), Jackson et al.
patent: 2002/0013295 (2002-01-01), Slusher et al.
patent: 2002/0015704 (2002-02-01), Bander
patent: 2002/0019430 (2002-02-01), Jackson et al.
patent: 2002/0151503 (2002-10-01), Slusher et al.
patent: 2003/0003101 (2003-01-01), Bander et al.
patent: 2003/0007974 (2003-01-01), Nanus et al.
patent: 2003/0017965 (2003-01-01), Slusher et al.
patent: 2003/0031673 (2003-02-01), Bander
patent: 2003/0064912 (2003-04-01), Slusher et al.
patent: 2003/0083374 (2003-05-01), Jackson et al.
patent: 2003/0105088 (2003-06-01), Tsukamoto et al.
patent: 2003/0216468 (2003-11-01), Tsukamoto et al.
patent: 2004/0001846 (2004-01-01), Israeli et al.
patent: 2004/0024188 (2004-02-01), Murphy et al.
patent: 0173951 (1986-12-01), None
patent: WO9409820 (1994-05-01), None
patent: 9626272 (1996-08-01), None
patent: WO9735616 (1997-10-01), None
patent: WO9947554 (1999-09-01), None
patent: 02096460 (2002-12-01), None
patent: 02098897 (2002-12-01), None
Lazar et al. Mol. Cell Biology 8(3):1247-62, Mar. 1988.
Bowie et al. Science 247:1308-1310, Mar. 1990.
Kumar et al. PNAS 87:1337-1341, Feb. 1990.
Abdel-Nabi, H., et al. (1992) “Monoclonal Antibodies and Radioimmunoconjugates in the Diagnosis and Treatment of Prostate Cancer”, Seminars on Urology 127: 45-54 (Exhibit 5).
Axelrod, H. R., et al. (1968) “Preclinical Results and Humman Immunohitochemical Studies With 90Y-CYT-356: A New Prostate Cancer Therapeutic Agent” AUA 87th Annual Meeting, May 10-14, 1992 (Exhibit 6).
Carter, B.H. And Coffey, D.S. (1990) “The Prostate: An Increasing Medical Problem” The Prostate 16:39-48 (Exhibit 7).
Feng, Q., et al. (1991) “Purification and Biochemical Characterization of the 7E11-C5 Prostate Carcinoma-Associated Antigen”, Proceedings of the American Association for Cancer Research 32:239 (Exhibit 8).
Chang, Chawnshang, et al. (1988) “Structural Analysis of Complementary DNA and Amino Acid Sequences of Human and Rat Androgen Receptors”, Proc. Natl Acad. Sci USA 85:7211-7215 (Exhibit 9).
Culver, K.W., et al. (1992) “In Vivo Gene Transfer with Retoviral Vector-Producer Cells for Treatment of Experimental Brain Tumors”, Science 256:1150-1552 (Exhibit 10).
Decensi, A., et al. (1991) “Phase II Study of the Pure Non-steroidal Antiandrogen Nilutamide in Prostatic Cancer”, Eur J Cancer 27:1100-1104 (Exhibit 11).
Faber, P.W., et al. (1991) “Characterization of the Human Androgen Transciption Unit” The Journal of Biological Chemistry 266:10743-10749 (Exhibit 12).
Fey, Martin F., et al. (1991) “The Polymerase Chain Reaction: A New Tool for the Detection of Minimal Residual Disease in Haematological Malignancies” Eur J Cancer 27:89-94 (Exhibit 13).
Henttu, Pirkko and Vihko, Pirkko (1989) “cDNA Coding for the Entire Human Prostate Specific Antigen Shows High Homologies to the Human Tissue Kallikrein Genes” Biochemical and Biophysical Research Communications 160:903-910 (Exhibit 14).
Horoszewicz, Julius S., et al. (1987) “Monoclonal Antibodies to a New Antigen Marker in Epithelial Prostatic Cells and Serum of Prostatic Cancer Patients” AntiCancer Research 7:927-936 (Exhibit 15).
Huber, Brian E., et al (1991) “Retroviral-mediated Gene Therapy for the Treatment of Hepatocellular Carcinoma: An Innovative Approach for Cancer Therapy” Proc. Natl. Acad. Sci. USA 88:8039-8043 (Exhibit 16).
Israeli, Ron S., et al. (1994) “Expression of the Prostate Specific Membrane Antigen” Cancer Research 54:1807-1811 (Exhibit 17).
Israeli, Ron S., et al. (1994) “Sensitive Nested Reverse Transcription Polymerase Chain Reaction Detection of Circulating Prostatic Tumor Cells: Comparison of Prostate-specific Membrane Antigen and Prostate-specific Antigen-based Assays” Cancer Research 5:6306-6310 (Exhibit 18).
Keer, Harold N., et al. (1990) “Elevated Transferrin Receptor Content in Human Prostate Cancer Cell Lines Assessed In Vitro and In Vivo” The Journal of Urology 143:381-385 (Exhibit 19).
Lopes, A. Dwight., et al (1993) “Immonohistochemical and Pharmacokinetic Characterization of the Site-specific Immunocnjugate CYT-356 Derived from Antiprostate Monoclonal Antibody” Cancer Research 50: 6423-6429 (Exhibit 20).
Lubahn, Dennis B., et al. (1989) “Sequence of the Intron/exon junctions of the Coding Region of the Human Adrogen Receptor Gene and Identification of a Point Mutation in a family with Complete Androgen Insensitivity” Proc. Natl. Acad. Sci. USA 86:9534-9538 (Exhibit 21).
Lundwall, Ake and Lilja, Hans., (1987) “Molecular Cloning of Human Prostate Specific Antigen cDNA” FEBS Letters 214, No. 2:317-322 (Exhibit 22).
Mukhopadhyay, Tapas., et al. (1991)“Sepecific Inhibitionof K-ras Expression and Tumorigenicity of Lung Cancer Cells by Antisense RNA” Cancer Research 51:1744-1748 (Exhibit 23).
Riegman, P.H.J., et al. (1989) “The Prostate-Specific Antigen Gene and the Human Glandular Kallikrein-1 Gene and Tandemly Located on Chromosone 19” FEBS Letters vol. 247:123-126 (Exhibit 24).
Sharief, Farida S., et al. “Human Prostatic Acid Phosphatase: cDNA Cloning, Gene Mapping and Protein Sequence Homology With Lysosomal Acid Phoshatase” Biochemical and Biophysical Research Communications 160:79-86 (Exhibit 25); 1990.
Solin, Timo., (1990) “Gene Expression and Prostate Specificity of Human Prostatic Acid Phosphatase (PAP): Evaluation By RNA Blot Analuses” Biochemica et Biophysica Acta 1048:72-77 (Exhibit 26).
Troyer, John K., et al.(1994) “Biochemical Characterization
Fair William R.
Heston Warren D. W.
Israeli Ron S.
Cooper & Dunham LLP
Gucker Stephen
Pak Michael
Sloan-Kettering Institute for Cancer Research
White, Esq. John P.
LandOfFree
Prostate-specific membrane antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostate-specific membrane antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostate-specific membrane antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3484310